0001539371-18-000002.txt : 20180507 0001539371-18-000002.hdr.sgml : 20180507 20180507145332 ACCESSION NUMBER: 0001539371-18-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180507 DATE AS OF CHANGE: 20180507 EFFECTIVENESS DATE: 20180507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kypha Inc. CENTRAL INDEX KEY: 0001539371 IRS NUMBER: 271009575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-311708 FILM NUMBER: 18810835 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 303 CITY: SAINT LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 314-932-4032 EXT 313 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 303 CITY: SAINT LOUIS STATE: MO ZIP: 63108 D/A 1 primary_doc.xml X0708 D/A LIVE 0001539371 Kypha Inc. 4320 FOREST PARK AVENUE SUITE 303 SAINT LOUIS MO MISSOURI 63108 314-932-4032 EXT 313 DELAWARE Kentucky Pharmaceuticals, Inc. None Corporation true Chad Stiening 4320 FOREST PARK AVENUE Suite 303 St. Louis MO MISSOURI 63108 Executive Officer Director James Merselis 4320 FOREST PARK AVENUE Suite 303 St. Louis MO MISSOURI 63108 Director Jonathan Sackier 4320 FOREST PARK AVENUE Suite 303 St. Louis MO MISSOURI 63108 Director Peter Reinecke 4320 FOREST PARK AVENUE Suite 303 St. Louis MO MISSOURI 63108 Director Other Health Care Decline to Disclose 06b true 0001539371-18-000001 2018-04-30 false true false 1 7852883 5457515 2395368 false 13 0 0 0 false Kypha Inc. /s/ Chad Stiening Chad Stiening CEO 2018-05-07